Cll Presentation

8/12/2019 Cll Presentation

1/21

Values Innovations


2/21

Year of Establishment: 19th Nov 1997

Founder: Dr.A.N.Singh

Managing Director and Chairman

ISO 9001 2008 Certified Company

The R&D facility is recognized by DSIRMember of AIBA

Origin


3/21

Vision

To be a leading global Bio Pharmaceutical

company driven by technology, innovation

and applied research & developmentmechanism.


4/21

Celestial Bio Labs Focus

Bio Pharmaceuticals

Herbal

Formulation

Allopathic

Formulation

Biotech

Formulation

Drug Development

Bio tools

Bio Informatics

IPR IPR


5/21

Biopharmaceuticals

Herbal, Allopathic and Biotech formulation

Bioinformatics

Molecular Modeling

Customized ERP dedicated to Healthcare

and retail chain

New Drug Molecule development and testing

Clinical trial & Clinical Data ManagementServices

Our Expertise


6/21

A) BIO-SERVICES

Gene sequence analysis

Molecular modeling

Clinical data management

Pharmaco vigilance Medical writing

ERP focused to pharma manufacturing

B) BIO PHARMACUTICAL FORMULATION

Herbal , Allopathic and Enzyme formulations

Our Business


7/21

Research Center :Bio Tool and Data Base Development

Biomolecules development:

Four New molecules with focus on Vitiligo, Wound healing,

Anti wrinkling and Tanning.

Neutraceuticals, Herbals and enzyme formulations.

Accelerating Clinical Development :

Both in-house and through partnerships

Developing Allopathic drugs through bio similar approach

and organizing clinical trailsFocus:

Core therapeutic areas with a project-based approach

Scientists:

Over 15

Research & Development


8/21

Dedicated and committed management team

Experienced scientists and technical team

ISO 9001 2008 Certified

New Drug development through Bioinformatics and

Bio Similar

Technological collaboration with leading research

institutions

IPR Generations

Key Strengths


9/21

Bio-IT Tools and Packages (6 nos)

Patents Under Process

Vitiligo new drug molecule

(12 nos) for different therapeutic application

concerning Herbal formulation

INTELLECTUAL PROPERTY RIGHTS (IPR)


10/21

OSMANIA

JNTU

IMTECH

IICT

CCMB

NIPER

Research Interaction


11/21

SHORT TERM:

Scaling of Existing Bio-Informatics/Informatics services

dedicated to pharma, chemical, biotech, medical centers,

hospitals and medicine retail chains.

Manufacturing and marketing of herbal, allopathic andBiotech formulations in India and overseas.

Developing and Promoting Nutraceuticals in INDIA and

Over Seas

LONG TERM:

Developing a range of medicines that has become off patent by

introducing important Phyto chemical/Herbal/Enzyme to

improve the efficacy and also to reduce side effects in order to

make it patentable medicine through bio similar approach .

BusinessStrategy


12/21

I

NT

E

G

R

AT

E

D

E

FF

O

R

T

STRATERGIC

VALUE CHAIN

LONGTERM

COST

COMPETITIVENESS

LEAVERAGE

INNOVATIONPRODUCTION

&

OPERATIONAL

EFFIENCY

BUSINESS

DEVELOPMENT

AND

MARKETING

INTELLECTUAL

PROPERTY RIGHTS

INNOVATION

Bioservices

Bioneutraceuticals

Custom Enzyme &

Biotech Formulation

Manufacturing

Business

Intelligence

ERP(BIO PHARMCUTICAL)

Integrated Business Model


13/21

1. Committed to progressive governance.

2. Accredited by DSIR.

3. Commitment to highest standards ofdisclosures & transparency.

4. Company listed in both NSE & BSE.

5. Code of Business Ethics.

6. Compliance with all regulatory affairs .

Corporate Governance


14/21

General features:R & D laboratory (Equipped forintegrated bench-topexperimentation and development)

Industrial Enzymes

Product and Quality control

Lab

Bioinformatics

model

LAB INFRASTRUCTURE


15/21

Board of DIRECTORS

Dr. A.N. Singh

B.tech, MBA, PhD (Technology Management With 3 Decades of

experience).

Dr. B.Siva Kumar

PhD in nutrition science with 35 yrs of experience.

Dr. Jeetainder Gour

PhD in Ayurveda with 12 yrs of experience.

Mrs. Padma SinghGraduate & Actively participating in Social works from last 15 yrs.


16/21

Dr. A.N. Singh

Bio Informatics experience in developing new drug molecules &conducting clinical trails

Dr. G.Bala Krishna

Extensive R&D experience in computer modeling, drug discovery &

clinical trails

Dr. Rama KrishnaR & D Experience in developing new Herbal formulations and

clinical trail management. Extensive working in Syrup, Tablet,

Capsules, Ointment & Granules.

Mr. B.Hari babu06 yrs of Design & Technology Integration

Mr. A. Anil Reddy

04 yrs of Design & Development of Data base & also conducting

clinical data testing & analysis .

RESEARCH & DEVELOPMENT GROUP


17/21

FINANCE & ADMINISTRATION

Mr. T.Ramesh (Senior Finance Manager)M.Com with 20 yrs of Accounting & Financial management

experience

Mr. P.Rama KrishnaB.Com with 15 yrs of Accounting & Financial management

experience

Mr. Arvind kumar

CFA with 8 yrs of Accounting , Financial management & Analyticalexperience


18/21

FINANCIAL STATEMENT2012 2013 2014 2015 2016 2017 2018

Particulars Actuval Proj. Proj. Proj. Proj. Proj. Proj.

Domestic Sales (Gross) 21.02 24.59 31.82 35.63 43.03 45.27 50.25

Export Sales ---- 0.00 0.00 0.00 0.00 0.00 0.00

Net Sales 21.02 24.59 31.82 35.63 43.03 45.27 50.25

% rise/fall (-) in net sales 1.33 3.00 4.00 5.00 6.00 7.00 8.00

Operating Profit 2.92 2.86 7.26 9.35 14.61 14.23 16.43

Profit Before tax 0.28 2.86 7.26 9.35 14.61 14.23 16.43

PBT/ Sales (%) 0.00 11.64 22.83 26.25 33.95 31.44 32.69

Profit After Tax 0.21 2.29 5.26 6.51 9.87 9.53 10.90

Cash Accrual 0.10 6.50 9.82 11.08 14.44 14.10 15.46

PBDIT 4.02 9.67 14.80 16.39 21.14 20.26 21.95

Paid Up Capital 14.60 14.60 14.60 14.60 14.60 14.60 14.60

TNW 0.00 70.72 76.28 83.10 93.20 102.73 113.63

Adjusted TNW 0.00 70.72 76.28 83.10 93.20 102.73 113.63

TOL/TNW (times) 0.00 0.34 0.27 0.20 0.14 0.10 0.06

Adjusted TOL/TNW 0.00 0.34 0.27 0.20 0.14 0.10 0.06

NWC 0.00 -17.65 -11.11 -3.32 7.74 18.24 33.70

Current Ratio 27.46 -0.95 -0.22 0.64 1.84 2.95 6.77

TTL/TNW 0.00 0.21 0.15 0.09 0.04 0.01 0.00

Current ratio without TL repay 0.00 -1.59 -0.37 1.05 3.01 4.79 6.77

TOL/TNW (treating USL as 0.18 0.33 0.26 0.20 0.14 0.09 0.05

Quasi Equity)


19/21

Mr. I.A. Chippa (Sale Manager)

B.SC (Biology) Two decades of sales & marketing experience inAllopathic & Herbal formulations. Product training & marketing

strategy is the key factor in his experience

Mr. Sunil Sharma, Mr.Pradeep khare, Mr. Avanti Das Mohapatra,Mr. Nitin j. Deshmukh, Mr. Madan Murari Pandey. (Regional

Sales Managers) along with their Area Sales managers and

Business development manager spread across INDIA

SENIOR MARKETING GROUP


20/21

Create a congenial work environment.

Strict conformity to current Good Manufacturing Practices (CGMP) and

Good Laboratory Practices (CGLP).

Continued R&D efforts for continuous improvement and to find new

solutions.

Create a scientific base to promote innovative R&D programs.

To seek active collaborations / partnerships from leading organisations in

India and abroad to complement our strengths.

To respect intellectual property rights.

CORE VALUES


21/21

MAILING ADDRESS:

CELESTIAL BIOLABS LIMITED

Plot No : 59, Road No : 12, APIIC Tech Park, IDA

Nacharam, Hyderabad-500076. A.P, INDIA

Phone : + 91 40 64565544, + 91 40 65552697

E-mail : [email protected] : www.celestialbiolabs.com

Documents

Cll Presentation